Related Experiment Videos
[Cytotoxic action of thiophosphamide on human tumor cells]
Abstract:
The cytotoxic action of thiophosphamide on the cells of 16 human tumor xenografts (lung, breast, colon and stomach carcinomas) was studied. The tumor xenografts placed into diffusion chambers were implanted into intact mice. It was demonstrated that thiophosphamide inhibits the progress of cancer cells to mitosis, reduces the rate of DNA synthesis and accumulation of the cells in mitosis and S-phase. The most pronounced and lasting alterations in cell proliferation were recorded in breast cancer, less significant in carcinoma of the stomach. These findings correlate with the data on the clinical efficacy of thiophosphamide applied to the treatment of these tumors.
Insights
Thiophosphamide effectively inhibits cancer cell proliferation, DNA synthesis, and mitosis across various human tumors. Breast cancer showed the most significant response to this cytotoxic agent.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- Thiophosphamide is a chemotherapeutic agent investigated for its cytotoxic effects.
- Understanding its impact on different human tumor xenografts is crucial for optimizing cancer treatment strategies.
Purpose of the Study:
- To investigate the cytotoxic action of thiophosphamide on human tumor xenografts.
- To evaluate the effects of thiophosphamide on cancer cell proliferation, DNA synthesis, and cell cycle progression.
Main Methods:
- Human tumor xenografts (lung, breast, colon, stomach carcinomas) were cultured in diffusion chambers.
- These xenografts were implanted into intact mice to assess thiophosphamide's in vivo effects.
- Cell proliferation, DNA synthesis, and cell cycle distribution (S-phase and mitosis) were analyzed.
Main Results:
- Thiophosphamide demonstrated cytotoxic effects by inhibiting cancer cell progression to mitosis.
- A reduction in DNA synthesis rate and accumulation of cells in mitosis and S-phase were observed.
- The most pronounced and lasting alterations in cell proliferation were noted in breast cancer xenografts.
- Less significant effects were observed in stomach carcinoma xenografts.
Conclusions:
- Thiophosphamide exhibits significant anti-cancer activity by disrupting cell proliferation and DNA synthesis.
- The differential response among tumor types, particularly the pronounced effect on breast cancer, suggests potential for targeted therapeutic applications.
- These findings align with existing clinical data on thiophosphamide's efficacy in treating specific human tumors.